Tag Archives: NX-1207

NX-1207 Trial – Adding Minimal Treatment to Active Surveillance

Question Of The Week: For patients on active surveillance, is there a new clinical trial you think is interesting?  Dr. Barken discusses the new trend of adding minimal  treatment to the active surveillance program. The related clinical trail: Two-Dose Level Evaluation of … Continue reading

Posted in Active Surveillance, Clinical Trials, Treatments for Prostate Cancer | Tagged | Leave a comment